Rhenman & Partners Asset Management AB

Position in LIVN — LivaNova PLC

CIK 1599882 Stockholm, V7

Position in LIVN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$9,851,800

-$1,838,900 QoQ

Shares Held

155,000

-18.4% QoQ

Ownership

0.282%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Rhenman & Partners Asset Management AB holds $125,056,277 across 12 Medical Devices names. LIVN ranks #6 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	625,000	$39,218,750
2	SYK	Stryker Corp	47,800	$15,706,602
3	EW	Edwards Lifesciences Corp	163,000	$13,053,040
4	PRCT	PROCEPT BioRobotics Corp	475,000	$11,879,750
5	ABT	Abbott Laboratories	112,000	$11,499,040
6	LIVN	LivaNova PLC This page	155,000	$9,851,800
7	GKOS	GLAUKOS Corp	84,000	$9,043,440
8	MDT	Medtronic plc	90,000	$7,798,500

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,851,800	155,000	-18.4%	Shares	Sole	2026-05-14
2025-12-31	$11,690,700	190,000	+258.5%	Shares	Sole	2026-02-13
2025-09-30	$2,776,140	53,000	0.0%	Shares	Sole	2025-11-13
2025-06-30	$2,386,060	53,000	+430.0%	Shares	Sole	2025-08-13
2021-06-30	$841,100	10,000	-93.5%	Shares	Sole	2021-08-13
2021-03-31	$11,428,150	155,000	-18.4%	Shares	Sole	2021-05-14
2020-12-31	$12,579,900	190,000	-9.5%	Shares	Sole	2021-01-19
2020-09-30	$9,494,100	210,000	-4.5%	Shares	Sole	2020-10-13
2020-06-30	$10,588,600	220,000	+15.8%	Shares	Sole	2020-07-16
2020-03-31	$8,597,500	190,000	—	Shares	Sole	2020-04-16
No filing history on record for this holder in this stock.